Chonluten (also known as Honluten) is a synthetic short-chain bioregulator peptide composed of three amino acids: L-Glycine, L-Glutamine, and L-Asparagine. It is primarily classified as a respiratory bioregulator, designed to mimic natural peptides that normalize the function of bronchial and lung tissue.

Core Mechanism of Action

Research indicates that Chonluten works at the epigenetic level. It is hypothesized to penetrate cell nuclei and interact directly with DNA strands and histones.

• Gene Regulation: It may modulate DNA methylation, helping to activate or repress specific genes involved in tissue repair and inflammation.
• Redox Balance: It is thought to upregulate antioxidant enzymes like Superoxide Dismutase (SOD) and glutathione, reducing oxidative stress in epithelial cells.
• Anti-Inflammatory: Studies suggest it inhibits the production of Tumor Necrosis Factor (TNF), a major pro-inflammatory cytokine, particularly in lung and mucosal tissues.

Key Reported Benefits

Clinical and laboratory data suggest Chonluten is most effective for respiratory and recovery-related applications:

Benefit Category	Specific Effects
Respiratory Health	Normalizes bronchial mucous membrane function; reduces frequency of coughing and choking in chronic conditions.
Athletic Performance	Research on high-level athletes showed increased aerobic capacity, improved oxygen pulse, and higher respiratory reserves.
Immune Modulation	Supports cellular adaptation and immune resilience by regulating cytokine signaling pathways.
Tissue Recovery	Promotes faster recovery of lung tissue following pneumonia, chemical burns, or prolonged mechanical ventilation.